Elsevier

Ceramics International

Volume 41, Issue 10, Part B, December 2015, Pages 13913-13966
Ceramics International

Review paper
Calcium orthophosphate bioceramics

https://doi.org/10.1016/j.ceramint.2015.08.004Get rights and content

Abstract

Various types of grafts have been traditionally used to restore damaged bones. In the late 1960s, a strong interest was raised in studying ceramics as potential bone grafts due to their biomechanical properties. A bit later, such synthetic biomaterials were called bioceramics. In principle, bioceramics can be prepared from diverse inorganic substances but this review is limited to calcium orthophosphate (CaPO4)-based formulations only, which possess the specific advantages due to the chemical similarity to mammalian bones and teeth. During the past 40 years, there have been a number of important achievements in this field. Namely, after the initial development of bioceramics that was just tolerated in the physiological environment, an emphasis was shifted towards the formulations able to form direct chemical bonds with the adjacent bones. Afterwards, by the structural and compositional controls, it became possible to choose whether the CaPO4-based implants remain biologically stable once incorporated into the skeletal structure or whether they were resorbed over time. At the turn of the millennium, a new concept of regenerative bioceramics was developed and such formulations became an integrated part of the tissue engineering approach. Now CaPO4-based scaffolds are designed to induce bone formation and vascularization. These scaffolds are usually porous and harbor various biomolecules and/or cells. Therefore, current biomedical applications of CaPO4-based bioceramics include bone augmentations, artificial bone grafts, maxillofacial reconstruction, spinal fusion, periodontal disease repairs and bone fillers after tumor surgery. Perspective future applications comprise drug delivery and tissue engineering purposes because CaPO4 appear to be promising carriers of growth factors, bioactive peptides and various types of cells.

Introduction

One of the most exciting and rewarding areas of the engineering discipline involves development of various devises for health care. Some of them are implantable. Examples comprise sutures, catheters, heart valves, pacemakers, breast implants, fracture fixation plates, nails and screws in orthopedics, various filling formulations, orthodontic wires, total joint replacement prostheses, etc. However, in order to be accepted by the living body without any unwanted side effects, all implantable items must be prepared from a special class of tolerable materials, called biomedical materials or biomaterials, in short. The physical character of the majority of the available biomaterials is solids [1], [2].

From the material point of view, all types of solids are divided into 4 major groups: metals, polymers, ceramics and various blends thereof, called composites. Similarly, all types of solid biomaterials are also divided into the same groups: biometals, biopolymers, bioceramics and biocomposites. All of them play very important roles in both replacement and regeneration of various human tissues; however, setting biometals, biopolymers and biocomposites aside, this review is focused on bioceramics only. In general, bioceramics comprise various polycrystalline materials, amorphous materials (glasses) and blends thereof (glass-ceramics). Nevertheless, the chemical elements used to manufacture bioceramics form just a small set of the Periodic Table. Namely, bioceramics might be prepared from alumina, zirconia, magnesia, carbon, silica-contained and calcium-contained compounds, as well as from a limited number of other chemicals. All these compounds might be manufactured in both dense and porous forms in bulk, as well as in the forms of crystals, powders, particles, granules, scaffolds and/or coatings [1], [2], [3].

As seen from the above, the entire subject of bioceramics is still rather broad. To specify it further, let me limit myself by a description of CaPO4-based formulations only. Due to the chemical similarity to mammalian bones and teeth, this type of bioceramics is used in a number of different applications throughout the body, covering all areas of the skeleton. The examples include healing of bone defects, fracture treatment, total joint replacement, bone augmentation, orthopedics, cranio-maxillofacial reconstruction, spinal surgery, otolaryngology, ophthalmology and percutaneous devices [1], [2], [3], as well as dental fillings and periodontal treatments [4]. Depending upon the required properties, different types of CaPO4 might be used. For example, Fig. 1 displays some randomly chosen samples of the commercially available CaPO4 bioceramics for bone graft applications. One should note that, in 2010, only in the USA the sales of bone graft substitutes were valued at ~$1.3 billion with a forecast of ~$2.3 billion by 2017 [5]. This clearly demonstrates an importance of CaPO4-based bioceramics.

A list of the available CaPO4, including their standard abbreviations and major properties, is summarized in Table 1 [6]. To narrow the subject further, with a few important exceptions, bioceramics prepared from undoped and un-substituted CaPO4 will be considered and discussed only. Due to this reason, CaPO4-based bioceramics prepared from biological resources, such as bones, teeth, corals, etc. [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], as well as the ion-substituted ones [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41] are not considered. The readers interested in both topics are advised to study the original publications.

Section snippets

General knowledge and definitions

A number of definitions have been developed for the term “biomaterials”. For example, by the end of the 20th century, the consensus developed by the experts was the following: biomaterials were defined as synthetic or natural materials to be used to replace parts of a living system or to function in intimate contact with living tissues [42]. However, in September 2009, a more advanced definition was introduced: “A biomaterial is a substance that has been engineered to take a form which, alone

History

The detailed history of HA and other types of CaPO4, including the subject of CaPO4 bioceramics, as well as description of their past biomedical applications might be found elsewhere [59], [60], where the interested readers are referred.

Chemical composition and preparation

Currently, CaPO4 bioceramics can be prepared from various sources [7], [8], [9], [10], [11], [12], [13], [14], [15]. Nevertheless, up to now, all attempts to synthesize bone replacement materials for clinical applications featuring the physiological tolerance,

Mechanical properties

The modern generation of biomedical materials should stimulate the body's own self-repairing abilities [329]. Therefore, during healing, a mature bone should replace the modern grafts and this process must occur without transient loss of the mechanical support. Unluckily for material scientists, a human body provides one of the most inhospitable environments for the implanted biomaterials. It is warm, wet and both chemically and biologically active. For example, a diversity of body fluids in

Biomedical applications

Since Levitt et al., described a method of preparing a FA bioceramics and suggested its possible use in medical applications in 1969 [601], CaPO4 bioceramics have been widely tested for clinical applications. Namely, a great number of forms, compositions and trade-marks (Table 3) currently are either in use or under a consideration in many areas of orthopedics and dentistry, with even more in development. For example, bulk materials, available in dense and porous forms, are used for alveolar

Biological properties and in vivo behavior

The most important differences between bioactive bioceramics and all other implanted materials comprise inclusion in the metabolic processes of the organism, adaptation of either surface or the entire material to the biomedium, integration of a bioactive implant with bone tissues at the molecular level or the complete replacement of a resorbable bioceramics by healthy bone tissues. All of the enumerated processes are related to the effect of an organism on the implant. Nevertheless, another

Non-biomedical applications of CaPO4

Due to their strong adsorption ability, surface acidity or basicity and ion exchange abilities, some types of CaPO4 possess a catalytic activity [15], [768], [769], [770], [771], [772], [773], [774], [775], [776], [777], [778], [779], [780]. As seen from the references, CaPO4 are able to catalyze oxidation and reduction reactions, as well as formation of C–C bonds. Namely, the application in oxidation reactions mainly includes oxidation of alcohol and dehydrogenation of hydrocarbons, while the

Tissue engineering

Tissue/organ repair has been the ultimate goal of surgery from ancient times to nowadays [56], [57]. The repair has traditionally taken two major forms: tissue grafting followed by organ transplantation and alloplastic or synthetic material replacement. Both approaches, however, have limitations. Grafting requires second surgical sites with associated morbidity and is restricted by limited amounts of material, especially for organ replacement. Synthetic materials often integrate poorly with

Conclusions and outlook

The available chronology of seeking for a suitable bioceramics for bone substitutes is as follows: since the 1950s, the first aim was to use bioinert bioceramics, which had no reaction with living tissues. They included inert and tolerant compounds, which were designed to withstand physiological stress without, however, stimulating any specific cellular responses. Later on, in the 1980s, the trend changed towards exactly the opposite: the idea was to implant bioceramics that reacted with the

References (946)

  • S. Kannan et al.

    Synthesis and mechanical behaviour of chlorapatite and chlorapatite/β-TCP composites

    J. Eur. Ceram. Soc.

    (2007)
  • N. Matsumoto et al.

    Thermal stability of β-tricalcium phosphate doped with monovalent metal ions

    Mater. Res. Bull.

    (2009)
  • E. Boanini et al.

    Ionic substitutions in calcium phosphates synthesized at low temperature

    Acta Biomater.

    (2010)
  • P. Habibovic et al.

    Bioinorganics and biomaterials: bone repair

    Acta Biomater.

    (2011)
  • M. Šupová

    Substituted hydroxyapatites for biomedical applications: a review

    Ceram. Int

    (2015)
  • D.F. Williams

    On the nature of biomaterials

    Biomaterials

    (2009)
  • M.A. Meyers et al.

    Biological materials: structure and mechanical properties

    Prog. Mater. Sci.

    (2008)
  • K. Tomoda et al.

    Hydroxyapatite particles as drug carriers for proteins

    Colloids Surf. B

    (2010)
  • O. Zamoume et al.

    Macroporous calcium phosphate ceramic implants for sustained drug delivery

    Mater. Sci. Eng. C

    (2011)
  • S. Bose et al.

    Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review

    Acta Biomater.

    (2012)
  • D. Arcos et al.

    Bioceramics for drug delivery

    Acta Mater.

    (2013)
  • P. Ducheyne et al.

    Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function

    Biomaterials

    (1999)
  • S.V. Dorozhkin

    A detailed history of calcium orthophosphates from 1770s till 1950

    Mater. Sci. Eng. C

    (2013)
  • M. Vallet-Regí et al.

    Calcium phosphates as substitution of bone tissues

    Prog. Solid State Chem.

    (2004)
  • K.A. Khalil et al.

    Novel mechanism to improve toughness of the hydroxyapatite bioceramics using high-frequency induction heat sintering

    J. Mater. Process. Technol.

    (2007)
  • S. Laasri et al.

    The affect of densification and dehydroxylation on the mechanical properties of stoichiometric hydroxyapatite bioceramics

    Mater. Res. Bull.

    (2010)
  • C.X. Wang et al.

    Influence of sintering temperatures on hardness and Young's modulus of tricalcium phosphate bioceramic by nanoindentation technique

    Mater. Charact.

    (2004)
  • M. Descamps et al.

    Manufacture of macroporous β-tricalcium phosphate bioceramics

    J. Eur. Ceram. Soc.

    (2008)
  • R.G. Carrodeguas et al.

    α-Tricalcium phosphate: synthesis, properties and biomedical applications

    Acta Biomater.

    (2011)
  • Y. Zhang et al.

    Fabrication and properties of porous β-tricalcium phosphate ceramics prepared using a double slip-casting method using slips with different viscosities

    Ceram. Int.

    (2012)
  • S.V. Dorozhkin

    Biphasic, triphasic and multiphasic calcium orthophosphates

    Acta Biomater.

    (2012)
  • M. Lukić et al.

    Dense fine-grained biphasic calcium phosphate (BCP) bioceramics designed by two-step sintering

    J. Eur. Ceram. Soc.

    (2011)
  • M. Descamps et al.

    Processing and properties of biphasic calcium phosphates bioceramics obtained by pressureless sintering and hot isostatic pressing

    J. Eur. Ceram. Soc.

    (2013)
  • Y. Chen et al.

    Enhanced effect of β-tricalcium phosphate phase on neovascularization of porous calcium phosphate ceramics: in vitro and in vivo evidence

    Acta Biomater.

    (2015)
  • Ž. Radovanović et al.

    Antimicrobial activity and biocompatibility of Ag+- and Cu2+-doped biphasic hydroxyapatite/α-tricalcium phosphate obtained from hydrothermally synthesized Ag+- and Cu2+-doped hydroxyapati

    Appl. Surf. Sci.

    (2014)
  • Y. Li et al.

    Novel highly biodegradable biphasic tricalcium phosphates composed of α-tricalcium phosphate and β-tricalcium phosphate

    Acta Biomater.

    (2007)
  • C. Zou et al.

    Characterization and dissolution–reprecipitation behavior of biphasic tricalcium phosphate powders

    J. Alloys Compd.

    (2011)
  • P. Ducheyne, K. Healy, D.E. Hutmacher, D.W. Grainger, C.J. Kirkpatrick (Eds.), Comprehensive Biomaterials. Six-Volume...
  • B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.), Biomaterials Science: An Introduction to Materials in...
  • M. Vallet-Regí

    Ceramics for medical applications

    J. Chem. Soc. Dalton Trans.

    (2001)
  • S.V. Dorozhkin

    Calcium orthophosphates in dentistry

    J. Mater. Sci. Mater. Med.

    (2013)
  • 〈http://www.prweb.com/releases/bone_grafts/standard_bone_allografts/prweb8953883.htm〉 (accessed June...
  • S.V. Dorozhkin

    Calcium Orthophosphates: Applications in Nature, Biology, and Medicine

    (2012)
  • F. Han et al.

    Preparing and characterizing natural hydroxyapatite ceramics

    Ceram. Int.

    (2010)
  • G. Gergely et al.

    Nano-hydroxyapatite preparation from biogenic raw materials

    Cent. Eur. J. Chem.

    (2010)
  • S. Mondal et al.

    Processing of natural resourced hydroxyapatite ceramics from fish scale

    Adv. Appl. Ceram.

    (2010)
  • K.T. Lim et al.

    Calcium phosphate bioceramics fabricated from extracted human teeth for tooth tissue engineering

    J. Biomed. Mater. Res. B: Appl. Biomater.

    (2011)
  • D.S. Seo et al.

    Fabrication of hydroxyapatite bioceramics from the recycling of pig bone

    J. Ceram. Process. Res

    (2012)
  • C. Piccirillo et al.

    Calcium phosphate-based materials of natural origin showing photocatalytic activity

    J. Mater. Chem. A

    (2013)
  • L.S. Zhao et al.

    Preparation and properties of porous β-tricalcium phosphate bone graft

    Adv. Mater. Res.

    (2013)
  • Cited by (205)

    View all citing articles on Scopus
    View full text